沙库巴曲缬沙坦钠联合琥珀酸美托洛尔治疗心力衰竭的临床效果
1资料和方法,2结果,3讨论
【摘要】目的:分析对心力衰竭患者实施沙库巴曲缬沙坦钠联合琥珀酸美托洛尔治疗的临床效果。方法:选择我院2023年1月—2023年12月期间收治的164例心力衰竭患者,随机分为对照组(82例,采用琥珀酸美托洛尔治疗)和观察组(82例,实施沙库巴曲缬沙坦钠联合琥珀酸美托洛尔治疗)。比较两组治疗效果。结果:观察组治疗总有效率明显高于对照组,差异显著(P<0.05);治疗后,观察组各项心功能指标均明显优于对照组,差异显著(P<0.05);两组不良反应发生率无明显差异(P>0.05)。结论:对心力衰竭患者实施沙库巴曲缬沙坦钠联合琥珀酸美托洛尔治疗的效果更佳,可显著改善心功能,促进氧化与抗氧化作用恢复正常,而且不会明显增加药物不良反应,有较高应用价值。【关键词】沙库巴曲缬沙坦钠;琥珀酸美托洛尔;心力衰竭;临床效果
Clinical efficacy of sacubitril valsartan sodium combined with metoprolol succinate in the treatment of heart failure
WANG Xuelian
Community Health Service Center in Dongsheng Town, Haidian District, Beijing City, Beijing 100192, China
【Abstract】Objective:To analyze the clinical efficacy of sacubitril valsartan sodium combined with metoprolol succinate in the treatment of heart failure patients.Methods:164 patients with heart failure admitted to our hospital from January 2023 to December 2023 were selected and randomly divided into the control group (82 cases,treated with metoprolol succinate) and the observation group (82 cases,treated with sacubitril valsartan sodium combined with metoprolol succinate).The therapeutic effects of the two groups were compared.Results:The total effective rate of treatment in the observation group was significantly higher than that in the control group ......
您现在查看是摘要页,全文长 9476 字符。